Matthew O'Brien
Stock Analyst at Piper Sandler
(0.08)
# 4,425
Out of 4,476 analysts
1251
Total ratings
36.9%
Success rate
-7.5%
Average return
Main Sectors:
Stocks Rated by Matthew O'Brien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Reiterated: Buy | $20 | $16.76 | +19.33% | 11 | Jun 22, 2026 | |
| MDT Medtronic | Reiterated: Hold | $91 → $85 | $83.19 | +2.18% | 58 | Jun 17, 2026 | |
| DXCM DexCom | Maintained: Buy | $75 → $88 | $71.25 | +23.51% | 66 | Jun 15, 2026 | |
| PODD Insulet | Maintained: Buy | $210 | $164.48 | +27.68% | 38 | Jun 15, 2026 | |
| GMED Globus Medical | Maintained: Buy | $115 → $100 | $80.12 | +24.81% | 55 | Jun 15, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $90 → $65 | $45.14 | +44.00% | 61 | Jun 12, 2026 | |
| HTFL HeartFlow | Reiterated: Buy | $38 | $27.97 | +35.88% | 4 | Jun 11, 2026 | |
| MMED MiniMed Group | Reiterated: Hold | $16 | $15.59 | +2.63% | 2 | Jun 4, 2026 | |
| CARL Carlsmed | Reiterated: Buy | $18 | $11.34 | +58.73% | 5 | Jun 3, 2026 | |
| TMDX TransMedics Group | Reiterated: Hold | $120 → $63 | $68.86 | -8.51% | 37 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $21.27 | -10.67% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.7214 | +38.62% | 26 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $9 | $4.19 | +114.80% | 9 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.60 | +114.29% | 23 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $26.98 | +11.19% | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $15.32 | +115.40% | 34 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $14 | $8.92 | +56.95% | 37 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $31.79 | +57.28% | 41 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $82 → $97 | $95.14 | +1.96% | 14 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $420 | $326.54 | +28.62% | 53 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $19.95 | +10.28% | 29 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $39 | $33.83 | +15.28% | 41 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $35 | $21.03 | +66.43% | 19 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.6369 | +371.03% | 1 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $17.11 | +46.11% | 6 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $330 → $374 | $318.57 | +17.40% | 18 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $87.47 | - | 42 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.5 | $5.45 | n/a | 24 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $27.79 | n/a | 12 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $245 → $140 | $133.99 | n/a | 26 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $11 | $5.06 | n/a | 20 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $180 | $148.34 | n/a | 62 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $4.5 → $2 | $4.30 | n/a | 26 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 → $3 | $0.71 | n/a | 7 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $44 | $18.05 | n/a | 38 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $90 | $0.0001 | n/a | 15 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $11 | $0.9357 | n/a | 7 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $10 | $1.41 | n/a | 24 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $82 | $22.65 | n/a | 16 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 → $79 | $71.09 | n/a | 25 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $31.35 | n/a | 14 | Jul 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.5 | $4.49 | n/a | 6 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 → $435 | $74.20 | n/a | 30 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 | $0.79 | n/a | 10 | Jan 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $7 | $0.000001 | n/a | 8 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $73 | $83.62 | n/a | 38 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $258 → $345 | $184.52 | n/a | 35 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 → $633 | $426.01 | n/a | 27 | Sep 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $3 | $8.02 | n/a | 3 | Jan 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $3.95 | n/a | 9 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 → $96 | $6.60 | n/a | 8 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $69 | $11.65 | n/a | 9 | Aug 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $70 | $209.63 | n/a | 8 | Aug 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.4129 | n/a | 2 | Aug 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.65 | n/a | 2 | May 8, 2012 |
Beta Bionics
Jun 22, 2026
Reiterated: Buy
Price Target: $20
Current: $16.76
Upside: +19.33%
Medtronic
Jun 17, 2026
Reiterated: Hold
Price Target: $91 → $85
Current: $83.19
Upside: +2.18%
DexCom
Jun 15, 2026
Maintained: Buy
Price Target: $75 → $88
Current: $71.25
Upside: +23.51%
Insulet
Jun 15, 2026
Maintained: Buy
Price Target: $210
Current: $164.48
Upside: +27.68%
Globus Medical
Jun 15, 2026
Maintained: Buy
Price Target: $115 → $100
Current: $80.12
Upside: +24.81%
Boston Scientific
Jun 12, 2026
Maintained: Buy
Price Target: $90 → $65
Current: $45.14
Upside: +44.00%
HeartFlow
Jun 11, 2026
Reiterated: Buy
Price Target: $38
Current: $27.97
Upside: +35.88%
MiniMed Group
Jun 4, 2026
Reiterated: Hold
Price Target: $16
Current: $15.59
Upside: +2.63%
Carlsmed
Jun 3, 2026
Reiterated: Buy
Price Target: $18
Current: $11.34
Upside: +58.73%
TransMedics Group
Jun 2, 2026
Reiterated: Hold
Price Target: $120 → $63
Current: $68.86
Upside: -8.51%
May 14, 2026
Maintained: Buy
Price Target: $19
Current: $21.27
Upside: -10.67%
May 13, 2026
Reiterated: Hold
Price Target: $1
Current: $0.7214
Upside: +38.62%
May 13, 2026
Maintained: Buy
Price Target: $15 → $9
Current: $4.19
Upside: +114.80%
May 12, 2026
Reiterated: Buy
Price Target: $12
Current: $5.60
Upside: +114.29%
May 11, 2026
Maintained: Buy
Price Target: $30
Current: $26.98
Upside: +11.19%
May 8, 2026
Maintained: Buy
Price Target: $33
Current: $15.32
Upside: +115.40%
May 6, 2026
Maintained: Buy
Price Target: $25 → $14
Current: $8.92
Upside: +56.95%
May 6, 2026
Reiterated: Buy
Price Target: $50
Current: $31.79
Upside: +57.28%
May 1, 2026
Maintained: Buy
Price Target: $82 → $97
Current: $95.14
Upside: +1.96%
May 1, 2026
Maintained: Buy
Price Target: $420
Current: $326.54
Upside: +28.62%
May 1, 2026
Maintained: Buy
Price Target: $22
Current: $19.95
Upside: +10.28%
Apr 30, 2026
Reiterated: Hold
Price Target: $39
Current: $33.83
Upside: +15.28%
Apr 30, 2026
Maintained: Buy
Price Target: $28 → $35
Current: $21.03
Upside: +66.43%
Apr 14, 2026
Initiated Coverage: Buy
Price Target: $3
Current: $0.6369
Upside: +371.03%
Mar 23, 2026
Reiterated: Buy
Price Target: $25
Current: $17.11
Upside: +46.11%
Jan 15, 2026
Downgraded: Hold
Price Target: $330 → $374
Current: $318.57
Upside: +17.40%
Oct 13, 2025
Maintained: Hold
Price Target: n/a
Current: $87.47
Upside: -
May 9, 2025
Maintained: Hold
Price Target: $3.5
Current: $5.45
Upside: n/a
May 8, 2025
Maintained: Hold
Price Target: $16
Current: $27.79
Upside: n/a
Feb 28, 2025
Downgraded: Hold
Price Target: $245 → $140
Current: $133.99
Upside: n/a
Feb 14, 2025
Maintained: Hold
Price Target: $12 → $11
Current: $5.06
Upside: n/a
Jan 27, 2025
Maintained: Buy
Price Target: $140 → $180
Current: $148.34
Upside: n/a
Aug 9, 2024
Rated: Hold
Price Target: $4.5 → $2
Current: $4.30
Upside: n/a
Nov 10, 2023
Reiterated: Hold
Price Target: $3.5 → $3
Current: $0.71
Upside: n/a
Jun 26, 2023
Maintained: Hold
Price Target: $55 → $44
Current: $18.05
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $10 → $90
Current: $0.0001
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $9 → $11
Current: $0.9357
Upside: n/a
Nov 9, 2021
Maintained: Buy
Price Target: $12 → $10
Current: $1.41
Upside: n/a
Sep 2, 2021
Maintained: Hold
Price Target: $82
Current: $22.65
Upside: n/a
Jul 30, 2021
Maintained: Buy
Price Target: $62 → $79
Current: $71.09
Upside: n/a
Jul 6, 2021
Maintained: Buy
Price Target: $70
Current: $31.35
Upside: n/a
Mar 23, 2021
Maintained: Hold
Price Target: $3.5
Current: $4.49
Upside: n/a
Feb 11, 2021
Maintained: Buy
Price Target: $370 → $435
Current: $74.20
Upside: n/a
Jan 27, 2021
Maintained: Hold
Price Target: $7
Current: $0.79
Upside: n/a
Jan 12, 2021
Maintained: Buy
Price Target: $4 → $7
Current: $0.000001
Upside: n/a
Jan 12, 2021
Reiterated: Buy
Price Target: $70 → $73
Current: $83.62
Upside: n/a
Jul 23, 2020
Maintained: Buy
Price Target: $258 → $345
Current: $184.52
Upside: n/a
Sep 25, 2019
Maintained: Buy
Price Target: $600 → $633
Current: $426.01
Upside: n/a
Jan 7, 2018
Reiterated: Buy
Price Target: $10 → $3
Current: $8.02
Upside: n/a
Dec 13, 2017
Reiterated: Buy
Price Target: $18
Current: $3.95
Upside: n/a
Nov 7, 2017
Reiterated: Hold
Price Target: $90 → $96
Current: $6.60
Upside: n/a
Aug 9, 2017
Reiterated: Buy
Price Target: $73 → $69
Current: $11.65
Upside: n/a
Aug 2, 2017
Reiterated: Hold
Price Target: $65 → $70
Current: $209.63
Upside: n/a
Aug 14, 2014
Maintained: Buy
Price Target: n/a
Current: $0.4129
Upside: n/a
May 8, 2012
Downgraded: Hold
Price Target: n/a
Current: $7.65
Upside: n/a